moracin m has been researched along with clioquinol in 1 studies
Studies (moracin m) | Trials (moracin m) | Recent Studies (post-2010) (moracin m) | Studies (clioquinol) | Trials (clioquinol) | Recent Studies (post-2010) (clioquinol) |
---|---|---|---|---|---|
21 | 0 | 13 | 1,060 | 59 | 218 |
Protein | Taxonomy | moracin m (IC50) | clioquinol (IC50) |
---|---|---|---|
kappa-type opioid receptor isoform 1 | Homo sapiens (human) | 5.79 | |
Amyloid-beta precursor protein | Homo sapiens (human) | 9.8 | |
Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | 5.6 | |
Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | 4.7863 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Li, W; Li, X; Wang, B; Wang, Y; Wang, Z | 1 |
1 other study(ies) available for moracin m and clioquinol
Article | Year |
---|---|
Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Benzofurans; Clioquinol; Cognition; Cyclic Nucleotide Phosphodiesterases, Type 4; Inflammation; Ligands; Male; Memory; Models, Molecular; Neurons; Neuroprotective Agents; Phosphodiesterase 4 Inhibitors; Protein Aggregates; Rats; Rats, Wistar; Resorcinols | 2015 |